Neil Kumar Net Worth & Insider Trades

Neil Kumar - Chief Executive Officer, Eidos Therapeutics, Inc

As of July 8, 2019

What is Neil Kumar's Net Worth?

The current estimated net worth of Eidos Therapeutics, Inc's Chief Executive Officer, Neil Kumar, is estimated to be about $671.66M . Neil Kumar owns about 24,575,501 units of Eidos Therapeutics, Inc common stock. In the last year at Eidos Therapeutics, Inc, Neil Kumar has sold an estimated value of $3.6M worth.

What is Neil Kumar's Past Insider Trading?

Neil Kumar's largest purchase order was 1,103,848 units , worth over $28.62M on May 29, 2019. Neil Kumar's largest sale order was 211,762 units , worth over $3.6M on June 22, 2018. In total, Neil Kumar has made about 3 transactions over a year of their time at Eidos Therapeutics, Inc. Neil Kumar usually trades in May, June and July, with the busiest year in 2019. The most recent transaction was a purchase order of 882,353 units , worth over $26.38M on July 8, 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Neil Kumar's Salary in 2020?

As Chief Executive Officer of Eidos Therapeutics, Inc, Neil Kumar has a total base salary of $550,000 . Neil Kumar received compensation valued at about $10,054,909 in 2020 after becoming Chief Executive Officer.

What is Neil Kumar's' Mailing Address?

  • Mailing address is C/o Eidos Therapeutics, Inc. 101 Montgomery Street, Suite 2550 San Francisco CA 94104 CA

What are Eidos Therapeutics, Inc's Past Insider Trades?

Eidos Therapeutics, Inc's most recent insider trade came on January 26, 2021 by Bridgebio Pharma Inc who bought 14,428,836 units worth $0 . In the last 3 years, insiders at Eidos Therapeutics, Inc have sold an estimated value of $34.74M and bought an estimated value of $352.62M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Jonathan Fox, See Remarks,  Cameron Turtle, Chief Business Officer,  and Christine Siu, CFO and Secretary .

Eidos Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1